TABLE 1.
Numbers of nasopharyngeal specimens examined for EV-D68, 2014 to 2018a
| Yr | No. of NPS tested | No. of NPS positive for RhV/EV (%) | No. of NPS tested for EV-D68 (%) | No. of NPS positive for EV-D68 (%) | No. of assembled genomes | EV-D68 clade (no. of strains) |
|---|---|---|---|---|---|---|
| 2014 | 3,762 | 917 (24.4) | 319 (34.8) | 94 (29.5) | 20 | Subclade B1 (18), B2 (2) |
| 2015 | 4,310 | 1,034 (24.0) | 199 (19.2) | 0 | 0 | |
| 2016 | 4,666 | 1,041 (22.3) | 654 (62.8) | 160 (24.5) | 22 | Subclade B3 (22) |
| 2017 | 4,298 | 889 (20.7) | 695 (78.2) | 5 (0.7) | 1 | Clade D (1) |
| 2018 | 4,612 | 1,068 (23.2) | 681 (63.8) | 89 (13.1) | 48 | Subclade B3 (37), Clade D (11) |
| Total | 21,648 | 4,949 (22.9) | 2,548 (51.5) | 348 (13.7) | 91 |
a
Data for 2014 and 2015 were adapted from reference 24. NPS, nasopharyngeal specimens.